Last reviewed · How we verify

Temporary discontinuation of statin therapy

Sint Franciscus Gasthuis · Phase 1 active Small molecule

Temporary discontinuation of statin therapy is a Small molecule drug developed by Sint Franciscus Gasthuis. It is currently in Phase 1 development. Also known as: e.g. Crestor, Lipitor.

At a glance

Generic nameTemporary discontinuation of statin therapy
Also known ase.g. Crestor, Lipitor
SponsorSint Franciscus Gasthuis
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Temporary discontinuation of statin therapy

What is Temporary discontinuation of statin therapy?

Temporary discontinuation of statin therapy is a Small molecule drug developed by Sint Franciscus Gasthuis.

Who makes Temporary discontinuation of statin therapy?

Temporary discontinuation of statin therapy is developed by Sint Franciscus Gasthuis (see full Sint Franciscus Gasthuis pipeline at /company/sint-franciscus-gasthuis).

Is Temporary discontinuation of statin therapy also known as anything else?

Temporary discontinuation of statin therapy is also known as e.g. Crestor, Lipitor.

What development phase is Temporary discontinuation of statin therapy in?

Temporary discontinuation of statin therapy is in Phase 1.

Related